Style | Citing Format |
---|---|
MLA | Ghavami A, et al.. "What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis." Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 5, 2021, pp. 956-965. |
APA | Ghavami A, Haghighian HK, Roshanravan N, Ziaei R, Ghaedi E, Moravejolahkami AR, Askari G (2021). What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis. Endocrine, Metabolic and Immune Disorders - Drug Targets, 21(5), 956-965. |
Chicago | Ghavami A, Haghighian HK, Roshanravan N, Ziaei R, Ghaedi E, Moravejolahkami AR, Askari G. "What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis." Endocrine, Metabolic and Immune Disorders - Drug Targets 21, no. 5 (2021): 956-965. |
Harvard | Ghavami A et al. (2021) 'What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis', Endocrine, Metabolic and Immune Disorders - Drug Targets, 21(5), pp. 956-965. |
Vancouver | Ghavami A, Haghighian HK, Roshanravan N, Ziaei R, Ghaedi E, Moravejolahkami AR, et al.. What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis. Endocrine, Metabolic and Immune Disorders - Drug Targets. 2021;21(5):956-965. |
BibTex | @article{ author = {Ghavami A and Haghighian HK and Roshanravan N and Ziaei R and Ghaedi E and Moravejolahkami AR and Askari G}, title = {What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis}, journal = {Endocrine, Metabolic and Immune Disorders - Drug Targets}, volume = {21}, number = {5}, pages = {956-965}, year = {2021} } |
RIS | TY - JOUR AU - Ghavami A AU - Haghighian HK AU - Roshanravan N AU - Ziaei R AU - Ghaedi E AU - Moravejolahkami AR AU - Askari G TI - What Is the Impact of Cinnamon Supplementation on Blood Pressure? a Systematic Review and Meta-Analysis JO - Endocrine, Metabolic and Immune Disorders - Drug Targets VL - 21 IS - 5 SP - 956 EP - 965 PY - 2021 ER - |